No Data
No Data
Raffles Medical Group Buys Back 700,000 Shares
Raffles Medical Group's (SGX:BSL) Shareholders Will Receive A Bigger Dividend Than Last Year
Global Equities Roundup: Market Talk
PhillipCapital Upgrades Raffles Medical Group to Accumulate From Neutral, Adjusts Price Target to SG$1.02 From SG$0.96
UOB Kay Hian Upgrades Raffles Medical Group to Buy From Hold, Adjusts Price Target to SG$1.06 From SG$1.01
Raffles Medical Group's Strong Financial Performance and Growth Potential Justifies Buy Rating